DelMar Pharma announces subscriptions of $2.0 million in registered direct offering
DelMar Pharmaceuticals announced it has accepted subscriptions from institutional and accredited investors for a registered direct placement of 3.35 million shares of common stock and 3.35 million common stock purchase warrants for aggregate purchases of $2 million. July 27, 2015